Opal BioSciences – Half-year Results
Opal Biosciences Limited – Half-year Financial Report 31 Dec 2017
Highlights: • LAIV flu vaccine royalty receipt • Progress in Opal’s bid to secure lease to GSK Boronia manufacturing plant • EOFY 2021 share price information Read the full annoucement
Announcement of Board Changes
